Celltrion shares jump on reports of bid interests from Roche, Teva, AstraZeneca
Jan 8 (Reuters) - Celltrion Inc shares jumped by 9.7 percent on Wednesday after South Korean media such as online news outlet Edaily reported that Roche Holding AG , Teva Pharmaceutical Industries Ltd and AstraZeneca Plc were among parties in talks to acquire the biotech firm.
Celltrion, the biggest firm in the country's second-tier KOSDAQ share market, said last week that its largest shareholder is in talks with interested parties to sell a controlling stake in the company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.